marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
ARCA biopharma Balance Sheet 2011-2024 | ABIO
Annual Balance Sheet ARCA biopharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-37.2 M | -42.1 M | -53 M | -48.7 M | -8.36 M | -6.61 M | -8.7 M | -7.4 M | -38.8 M | -15.4 M | -16.8 M | -2.92 M | -5.94 M |
Long Term Debt |
204 K | 280 K | 383 K | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
76 K | 103 K | - | - | 25 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 409 K | - | - | 20 K | 39 K | - | 3 K | 1 K | - | 16 K |
Total Current Liabilities |
637 K | 1.13 M | 3.5 M | 3.5 M | 926 K | 793 K | 2.07 M | 2.4 M | 1.5 M | 1.39 M | 1.5 M | 305 K | 754 K |
Total Liabilities |
841 K | 1.41 M | 3.88 M | 3.91 M | 926 K | 793 K | 2.09 M | 2.44 M | 1.5 M | 1.39 M | 1.5 M | 305 K | 770 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-189 M | -183 M | -173 M | -154 M | -144 M | -139 M | -131 M | -113 M | -96.1 M | -84.6 M | -74.9 M | -68 M | -63.7 M |
Total Assets |
37.9 M | 43.1 M | 54.9 M | 50.4 M | 8.54 M | 6.82 M | 12.4 M | 24.6 M | 39.6 M | 16.1 M | 17.1 M | 3.21 M | 6.5 M |
Cash and Cash Equivalents |
37.4 M | 42.4 M | 53.4 M | 49.1 M | 8.36 M | 6.61 M | 8.7 M | 7.4 M | 38.8 M | 15.4 M | 16.8 M | 2.92 M | 5.94 M |
Book Value |
37 M | 41.7 M | 51 M | 46.5 M | 7.61 M | 6.03 M | 10.3 M | 22.2 M | 38.1 M | 14.7 M | 15.6 M | 2.91 M | 5.73 M |
Total Shareholders Equity |
37 M | 41.7 M | 51 M | 46.5 M | 7.61 M | 6.03 M | 10.3 M | 22.2 M | 38.1 M | 14.7 M | 15.6 M | 2.91 M | 5.73 M |
All numbers in USD currency
Quarterly Balance Sheet ARCA biopharma
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
842 K | - | - | 204 K | 224 K | 243 K | 262 K | 280 K | 301 K | - | 357 K | 383 K | 410 K | 435 K | 394 K | 409 K | 409 K | 409 K | 409 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
18.9 M | 1.27 M | 1.58 M | 841 K | 1.22 M | 1.84 M | 1.53 M | 1.41 M | 2.24 M | - | 3.08 M | 3.88 M | 3.59 M | 4.13 M | 3.27 M | 3.91 M | 3.91 M | 3.91 M | 3.91 M | 926 K | - | - | - | 793 K | 982 K | 1.07 M | 1.73 M | 2.09 M | 2.09 M | 2.09 M | 2.09 M | 2.44 M | 2.44 M | 2.44 M | 2.44 M | 1.5 M | 1.5 M | 1.5 M | 1.13 M | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 305 K | 305 K | 305 K | 305 K | 770 K | 770 K | 770 K | 770 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-57.9 M | -193 M | -191 M | -189 M | -188 M | -186 M | -185 M | -183 M | -182 M | - | -177 M | -173 M | -168 M | -163 M | -158 M | -154 M | -154 M | -154 M | -154 M | -144 M | -144 M | -144 M | -144 M | -139 M | -139 M | -139 M | -139 M | -131 M | -131 M | -131 M | -131 M | -113 M | -113 M | -113 M | -113 M | -96.1 M | -96.1 M | -96.1 M | -96.1 M | -84.6 M | -84.6 M | -84.6 M | -84.6 M | -74.9 M | -74.9 M | -74.9 M | -74.9 M | -68 M | -68 M | -68 M | -68 M | -63.7 M | -63.7 M | -63.7 M | -63.7 M |
Total Assets |
414 M | 33.8 M | 36.7 M | 37.9 M | 39.2 M | 41.1 M | 42.1 M | 43.1 M | 45 M | - | 51 M | 54.9 M | 60.2 M | 65.3 M | 69.2 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 8.54 M | 8.54 M | 8.54 M | 8.54 M | 6.82 M | 6.82 M | 6.82 M | 6.82 M | 12.4 M | 12.4 M | 12.4 M | 12.4 M | 24.6 M | 24.6 M | 24.6 M | 24.6 M | 39.6 M | 39.6 M | 39.6 M | 39.6 M | 16.1 M | 16.1 M | 16.1 M | 16.1 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 3.21 M | 3.21 M | 3.21 M | 3.21 M | 6.5 M | 6.5 M | 6.5 M | 6.5 M |
Cash and Cash Equivalents |
411 M | 33.3 M | 35.9 M | 37.4 M | 38.5 M | 40.2 M | 40.8 M | 42.4 M | 43.9 M | 46.4 M | 49.1 M | 53.4 M | 58.3 M | 63.2 M | 66.9 M | 49.1 M | 49.1 M | 49.1 M | 49.1 M | 8.36 M | 8.36 M | 8.36 M | 8.36 M | 6.61 M | 6.61 M | 6.61 M | 6.61 M | 8.7 M | 8.7 M | 8.7 M | 8.7 M | 7.4 M | 7.4 M | 7.4 M | 7.4 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 2.92 M | 2.92 M | 2.92 M | 2.92 M | 5.94 M | 5.94 M | 5.94 M | 5.94 M |
Book Value |
395 M | 32.6 M | 35.1 M | 37 M | 38 M | 39.2 M | 40.5 M | 41.7 M | 42.7 M | - | 47.9 M | 51 M | 56.6 M | 61.2 M | 65.9 M | 46.5 M | 46.5 M | 46.5 M | 46.5 M | 7.61 M | 8.54 M | 8.54 M | 8.54 M | 6.03 M | 5.84 M | 5.76 M | 5.09 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 38.1 M | 38.1 M | 38.1 M | 38.4 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 2.91 M | 2.91 M | 2.91 M | 2.91 M | 5.73 M | 5.73 M | 5.73 M | 5.73 M |
Total Shareholders Equity |
342 M | 32.6 M | 35.1 M | 37 M | 38 M | 39.2 M | 40.5 M | 41.7 M | 42.7 M | 45 M | 47.9 M | 51 M | 56.6 M | 61.2 M | 65.9 M | 46.5 M | 46.5 M | 46.5 M | 46.5 M | 7.61 M | 7.61 M | 7.61 M | 7.61 M | 6.03 M | 6.03 M | 6.03 M | 6.03 M | 10.3 M | 10.3 M | 10.3 M | 10.3 M | 22.2 M | 22.2 M | 22.2 M | 22.2 M | 38.1 M | 38.1 M | 38.1 M | 38.1 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 2.91 M | 2.91 M | 2.91 M | 2.91 M | 5.73 M | 5.73 M | 5.73 M | 5.73 M |
All numbers in USD currency